Articles published by Telix Pharmaceuticals Limited
CMS Grants Transitional Pass-Through Status for Gozellix
September 23, 2025
Telix H1 2025 Results: Investor Webcast Notification
July 29, 2025
Telix Reports $204M Revenue, Up 63% YOY
July 22, 2025
Gozellix Receives Permanent HCPCS Code
July 09, 2025
Telix's Illuccix PSMA-PET Imaging Agent Approved in France
April 28, 2025
Telix Reports US$186M Q1 Revenue, Up 62% YOY
April 22, 2025
Telix Appoints Paul Schaffer as Chief Technology Officer
April 07, 2025
Anne Whitaker Appointed as Non-Executive Director
April 03, 2025
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
March 21, 2025
Telix Adds Lead-212 Isotope Production Capability
March 12, 2025
Illuccix® Approved in the United Kingdom
February 12, 2025
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|
